396 related articles for article (PubMed ID: 15290916)
1. Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.
Herrlinger KR; Dittmann R; Weitz G; Wehkamp J; Ludwig D; Schwab M; Stange EF; Fellermann K
Inflamm Bowel Dis; 2004 May; 10(3):229-33. PubMed ID: 15290916
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease.
Oruç N; Ozütemiz O; Osmanoğlu N; Ilter T
Turk J Gastroenterol; 2009 Mar; 20(1):9-12. PubMed ID: 19330729
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum procalcitonin in patients with ulcerative colitis.
Koido S; Ohkusa T; Takakura K; Odahara S; Tsukinaga S; Yukawa T; Mitobe J; Kajihara M; Uchiyama K; Arakawa H; Tajiri H
World J Gastroenterol; 2013 Dec; 19(45):8335-41. PubMed ID: 24363525
[TBL] [Abstract][Full Text] [Related]
4. Additional benefit of procalcitonin to C-reactive protein to assess disease activity and severity in Crohn's disease.
Oussalah A; Laurent V; Bruot O; Guéant JL; Régent D; Bigard MA; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2010 Nov; 32(9):1135-44. PubMed ID: 21039675
[TBL] [Abstract][Full Text] [Related]
5. Role of procalcitonin in infectious gastroenteritis and inflammatory bowel disease.
Thia KT; Chan ES; Ling KL; Ng WY; Jacob E; Ooi CJ
Dig Dis Sci; 2008 Nov; 53(11):2960-8. PubMed ID: 18415679
[TBL] [Abstract][Full Text] [Related]
6. Serum procalcitonin and C-reactive protein in children with diarrhoea of various aetiologies.
Korczowski B; Szybist W
Acta Paediatr; 2004 Feb; 93(2):169-73. PubMed ID: 15046268
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin in Crohn's disease with fever episodes, a variable to differentiate intra-abdominal abscess from disease flares.
Ge X; Hu D; Cao Y; Liu Z; Ding C; Tian H; Gong J; Zhu W; Li N; Li J
Int J Surg; 2016 Dec; 36(Pt A):34-39. PubMed ID: 27743896
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
Sitter T; Schmidt M; Schneider S; Schiffl H
J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
[TBL] [Abstract][Full Text] [Related]
9. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?
Delèvaux I; André M; Colombier M; Albuisson E; Meylheuc F; Bègue RJ; Piette JC; Aumaître O
Ann Rheum Dis; 2003 Apr; 62(4):337-40. PubMed ID: 12634233
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
11. Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus.
Yu J; Xu B; Huang Y; Zhao J; Wang S; Wang H; Yang N
Mod Rheumatol; 2014 May; 24(3):457-63. PubMed ID: 24252006
[TBL] [Abstract][Full Text] [Related]
12. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.
Gendrel D; Raymond J; Coste J; Moulin F; Lorrot M; Guérin S; Ravilly S; Lefèvre H; Royer C; Lacombe C; Palmer P; Bohuon C
Pediatr Infect Dis J; 1999 Oct; 18(10):875-81. PubMed ID: 10530583
[TBL] [Abstract][Full Text] [Related]
13. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin in inflammatory bowel disease: Drawbacks and opportunities.
Lippi G; Sanchis-Gomar F
World J Gastroenterol; 2017 Dec; 23(47):8283-8290. PubMed ID: 29307988
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of procalcitonin, C-reactive protein, interleukin-6 & serum amyloid A as diagnostic biomarkers of bacterial infection in febrile patients.
Qu J; L X; Liu Y; Wang X
Indian J Med Res; 2015 Mar; 141(3):315-21. PubMed ID: 25963492
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
[TBL] [Abstract][Full Text] [Related]
17. Procalcitonin is a specific marker for detecting bacterial infection in patients with rheumatoid arthritis.
Sato H; Tanabe N; Murasawa A; Otaki Y; Sakai T; Sugaya T; Ito S; Otani H; Abe A; Ishikawa H; Nakazono K; Kuroda T; Nakano M; Narita I
J Rheumatol; 2012 Aug; 39(8):1517-23. PubMed ID: 22753652
[TBL] [Abstract][Full Text] [Related]
18. Early detection of an early onset infection in the neonate based on measurements of procalcitonin and C-reactive protein concentrations in cord blood.
Kordek A; Hałasa M; Podraza W
Clin Chem Lab Med; 2008; 46(8):1143-8. PubMed ID: 18590465
[TBL] [Abstract][Full Text] [Related]
19. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus.
Quintana G; Medina YF; Rojas C; Fernandez A; Restrepo JF; Rondon F; Iglesias A
J Clin Rheumatol; 2008 Jun; 14(3):138-42. PubMed ID: 18525431
[TBL] [Abstract][Full Text] [Related]
20. Pro-calcitonin and inflammation in chronic hemodialysis.
Trimarchi H; Dicugno M; Muryan A; Lombi F; Iturbe L; Raña MS; Young P; Nau K; Iriarte R; Pomeranz V; Forrester M; Karl A; Alonso M
Medicina (B Aires); 2013; 73(5):411-6. PubMed ID: 24152395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
